Clinical Trials Logo

Clinical Trial Summary

Single arm phase II PDR001( 300mg, IV) will be treated every 3 weeks


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03785496
Study type Interventional
Source Yonsei University
Contact
Status Active, not recruiting
Phase Phase 2
Start date February 18, 2020
Completion date January 2024